Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which colonoscopy prep is kinder to kids with IBD? a trial puts two to the test

NCT ID NCT07786363

Disease control Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial compares two bowel-cleansing regimens for colonoscopy in children with inflammatory bowel disease (IBD). One uses a high-volume polyethylene glycol (PEG) solution, while the other uses a lower-volume sodium picosulfate and magnesium oxide preparation. The study will measure how well each cleans the colon and how tolerable children find them, aiming to identify a more comfortable yet effective option for young patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
polyethylene glycol (PEG) or sodium picosulfate with magnesium oxide
What this could lead to
If one preparation works better or is easier to tolerate, it could improve the colonoscopy experience for children with IBD, leading to better bowel cleansing and more accurate diagnoses.
What could go wrong
This is a relatively small study, and results may not apply to all children. Both preparations can cause side effects like nausea, bloating, or abdominal pain, and neither may prove clearly superior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

125 people

The number who actually took part.

Started

Jun 2023

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * suspected IBD or IBD diagnosed according to the widely accepted Porto criteria (incorporating clinical, endoscopic, and histopathological criteria); * eligibility for colonoscopy; * normal laboratory test results: sodium, potassium, and creatinine levels; * informed consent from the child's parents or guardians for participation in the study; for children over 16 years of age, additional consent from the child participating in the study. Exclusion Criteria: * following gastrointestinal surgery; * with renal failure or heart failure; * with conditions other than IBD that constitute an indication for colonoscopy; * whose parents or guardians have not consented to participation in the study; or, in the case of children over 16 years of age, lack of consent from the child.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colonoscopy preparation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colonoscopy preparation

Contacts and locations

Locations

  • Department of Pediatric Gastroenterology and Nutrition

    Warsaw, 02-091, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.